BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS ARTICLE NO. 228, 489–[removed]

First Page		Document Content
Date: 2013-04-05 08:29:33 Cell signaling CD80 CD86 Protein methods B7 CTLA-4 Tyrosine kinases CD28 Immunoprecipitation Biology Cell biology T cells		BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS ARTICLE NO. 228, 489–[removed] Add to Reading List Source URL: people.img.cas.cz Download Document from Source Website File Size: 82,61 KB Share Document on Facebook

	· NSCLC · PD-(L)1 Inhibitors and CTLA-4 Inhibitors: Rationale for Combinations and Recent Data in Non-Small Cell Lung Cancer Rebecca S. Heist, MD, MPH DocID: 1lZbh - View Document
	A new mathematical model for the interpretation of translational research evaluating six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon compared with healthy controls Petr Pancoska1, Jo DocID: 1l7KM - View Document
	Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma DocID: 1gd5U - View Document
	Toxicity from Checkpoint Inhibitors James Larkin FRCP PhD Disclosures DocID: 1a5xh - View Document
	ENDOTHELIAL CELL ANTIBODIES AS BIOMARKERS FOR REJECTION IN KIDNEY TRANSPLANT BACHELOR PAPER Il Submitted at: Austrian Marshall Plan Foundation DocID: 19DqA - View Document